If you're a woman taking GLP-1 medications and thinking about pregnancy — or if you're wondering whether GLP-1 could affect your fertility — you're not alone. These are among the most common questions we hear.
Here's what the research tells us about GLP-1, fertility, and pregnancy.
GLP-1 and Fertility
The Good News: GLP-1 May Improve Fertility
For women with PCOS (polycystic ovary syndrome) or obesity-related infertility, GLP-1 medications may actually improve fertility:
- Weight loss from GLP-1 can restore ovulation in women with irregular cycles
- Improved insulin sensitivity helps regulate hormones
- PCOS-specific benefits: Studies show GLP-1 can improve menstrual regularity and ovulation rates in women with PCOS
See our PCOS and GLP-1 guide for more.
A Word of Caution
Because GLP-1 can improve fertility, women who weren't able to conceive before may find themselves unexpectedly pregnant. This is why contraception counseling is important when starting GLP-1.
GLP-1 and Pregnancy: What We Know
Current Recommendation: Stop Before Pregnancy
All GLP-1 medications carry the following guidance:
- Discontinue at least 2 months before planned conception (semaglutide)
- Discontinue at least 1 month before planned conception (liraglutide, tirzepatide)
This is because GLP-1 stays in your system for weeks after your last dose, and we want to ensure it's fully cleared before pregnancy begins.
Why the Warning?
Animal studies have shown that GLP-1 medications can cause fetal harm, including:
- Growth restriction
- Structural abnormalities
- Pregnancy loss
Human data is limited but growing. Here's what we know so far:
Human Pregnancy Data
| Study | Medication | Findings |
|---|---|---|
| Danish registry (2023) | Semaglutide | No increased risk of major birth defects vs. general population |
| Small cohort studies | Various GLP-1s | No clear signal of harm, but sample sizes are small |
| Ongoing trials | Semaglutide | Results pending |
Bottom line: No clear evidence of harm in humans yet, but data is too limited to declare GLP-1 safe during pregnancy. The precautionary principle applies.
GLP-1 and Weight Gain During Pregnancy
One concern women have is: "If I stop GLP-1, will I regain all my weight during pregnancy?"
The honest answer: Some weight regain is possible, but not inevitable. Here's what can help:
- Work with your OB/GI team on a pregnancy nutrition plan
- Focus on nutrient-dense foods to support baby's development
- Stay active as approved by your doctor
- Monitor weight gain within your doctor's recommended range
GLP-1 and Breastfeeding
Current guidance: There is insufficient data on GLP-1 medications in breast milk. Most experts recommend avoiding GLP-1 while breastfeeding until more data is available.
Semaglutide has a long half-life (about 1 week), so it could potentially pass into breast milk. The risk to the infant is unknown.
Planning Pregnancy on GLP-1: A Timeline
If you're planning to conceive, here's a suggested timeline:
2-3 Months Before Conception
- Stop semaglutide (Wegovy, Ozempic, Rybelsus)
- Switch to alternative diabetes management if needed (insulin is safe in pregnancy)
- Start prenatal vitamins with folic acid
- Schedule preconception counseling with your OB/GYN
1-2 Months Before Conception
- Stop liraglutide (Saxenda, Victoza) or tirzepatide (Mounjaro, Zepbound)
- Confirm medication is cleared from your system
- Optimize nutrition and weight
During Pregnancy
- Focus on healthy weight gain as recommended by your OB
- Monitor blood sugar closely (if diabetic)
- Maintain a balanced diet with adequate protein
- Stay active as approved by your doctor
After Pregnancy
- Discuss with your doctor when it's safe to restart GLP-1
- If breastfeeding, most experts recommend waiting until after weaning
- If not breastfeeding, restart timing is individual
What If I Got Pregnant While on GLP-1?
Don't panic. Here's what to do:
- Stop the medication immediately
- Tell your doctor — they'll want to monitor you closely
- Don't assume the worst — limited human data hasn't shown clear harm
- Get early prenatal care — your OB may recommend additional monitoring
Many women have had healthy pregnancies after inadvertent GLP-1 exposure in early pregnancy. The key is to stop the medication and get appropriate prenatal care.
The Bottom Line
- GLP-1 may improve fertility in women with PCOS or obesity-related infertility
- Stop GLP-1 before trying to conceive (2 months for semaglutide, 1 month for others)
- Limited human data hasn't shown clear harm, but it's too early to declare safety
- Plan ahead with your healthcare team
- Don't panic if you get pregnant while on GLP-1 — stop the medication and get prenatal care
Talk to your doctor about a personalized plan for your situation.
This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider about your specific situation.
